Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Learning from COVID-19: How drug hunters can prepare for the next pandemic

Drug Discovery Today(2023)10.1016/j.drudis.2023.103723Source: DataRank Database

Learning from COVID-19: How drug hunters can prepare for the next pandemic is a research paper published in Drug Discovery Today (2023). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.84)OA: greenTopics (32)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Thomas R. Lane ORCID,Sean Ekins ORCID,Ana C. Puhl ORCID

Live enrichment

PubMed:37482237 PMC:PMC10994687 OpenAlex:https://openalex.org/W4385076004

NCCAM

Grant: 1R43AT010585-01

National Institute of General Medical Sciences

Grant: R44GM122196-02A1

NCCIH NIH HHS

Grant: R43 AT010585

NIGMS NIH HHS

Grant: R44 GM122196

National Institutes of Health

National Center for Complementary and Alternative Medicine

National Institute of Allergy and Infectious Diseases

FWCI

0.84

Citation Percentile

0.8%

Citation Trend

2023

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10994687/pdf/nihms-1978789.pdf

publisherhttps://api.elsevier.com/content/article/PII:S1359644623002398?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1359644623002398?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10994687

Fields of Study

Computational Drug Discovery MethodsSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

MeSH Terms

COVID-19SARS-CoV-2Antiviral AgentsHumansTiloroneDrug RepositioningPandemics

Keywords

PanobinostatRepurposingPandemicCoronavirus disease 2019 (COVID-19)Drug discoveryDrug repositioningSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PharmacologyDrug2019-20 coronavirus outbreakMedicineVirologyOutbreakChemistryInfectious disease (medical specialty)BioinformaticsBiologyDiseaseInternal medicineAntiviralsEbolaCovid-19

Sustainable Development Goals

SDG 0: Good health and well-being